Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | USP8 | P40818 | 1/20 | 0.38 |
| ▸ | USP7 | Q93009 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30940563 | 0.85 | TRPA1 (0.50) | ESR2TYRTSHRTRPA1NOTUM | |
| SCHEMBL1033059 | 0.85 | TRPA1 (0.50) | ESR2TYRTSHRTRPA1NOTUM | |
| SCHEMBL17954603 | 0.79 | DRD2 (0.46) | ESR2TYRTRPA1NISCHNOTUM | |
| SCHEMBL11679308 | 0.78 | PNMT (0.40) | TYRTRPA1NISCHNOTUMPDK2 | |
| SCHEMBL17954611 | 0.78 | TRPA1 (0.38) | TYRTRPA1NISCHNOTUMPDK2 | |
| Pyridine SCHEMBL11066795 | 0.75 | TRPA1 (0.46) | TRPA1NISCHNOTUMKDM4EALDH1A1 | |
| SCHEMBL4923692 | 0.75 | TRPA1 (0.53) | TSHRTRPA1NOTUMCA1CA2 | |
| SCHEMBL19254753 | 0.75 | TRPA1 (0.45) | ESR2TYRTSHRTRPA1NOTUM | |
| SCHEMBL28405842 | 0.74 | PNMT (0.49) | ESR2TSHRTRPA1CA1CA2 | |
| SCHEMBL4825821 | 0.74 | NOTUM (0.49) | ESR2TSHRTRPA1NOTUMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382241-B1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORP (JP) | 2016-11-23 | — | — | EP | claimed |
| US-8785566-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2014-07-22 | — | — | US | claimed |
| US-10081688-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2018-09-25 | — | — | US | disclosed |
| US-20170002112-A1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| EP-2382241-B1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORP (JP) | 2016-11-23 | — | — | EP | disclosed |
| US-9447213-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20160218300-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-07-28 | — | — | US | disclosed |
| US-20140275403-A1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2014-09-18 | — | — | US | disclosed |
| US-8785566-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2014-07-22 | — | — | US | disclosed |
| CN-102361888-B | Polymers functionalized with polycyano compounds | BRIDGESTONE CORP | 2013-11-20 | — | — | CN | disclosed |
| CN-102361888-A | Polymers functionalized with polycyano compounds | BRIDGESTONE CORP | 2012-02-22 | — | — | CN | disclosed |
| US-20110288200-A1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2011-11-24 | — | — | US | disclosed |
| EP-2382241-A2 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | Bridgestone Corporation (JP) | 2011-11-02 | — | — | EP | disclosed |
| WO-2010085631-A2 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160218300-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, OSBP | ESR2 546/4885TYR 878/4885TSHR 4669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.